EVP, GC
Joy Liu is a seasoned legal executive serving as Senior Vice President, General Counsel, Corporate Secretary, and Chief Risk Officer at Vertex Pharmaceuticals Incorporated (VRTX), where she joined in 2016.[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/joy-liu)[[2]](https://www.conferencesforwomen.org/speakers/joy-liu/)[[3]](https://rocketreach.co/joy-liu-email_392453638) She oversees all aspects of the Legal department, Office of Business Integrity and Ethics, and serves on the company's Executive Committee. Previously, as Senior Vice President and Deputy General Counsel, she provided counsel on legal, regulatory, privacy, and business contracting matters across global functions.[[2]](https://www.conferencesforwomen.org/speakers/joy-liu/) Liu has held various senior leadership roles at Vertex, including Vice President of Commercial and Regulatory Legal.[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/joy-liu)[[5]](https://www.fdli.org/2017/01/fdli-welcomes-new-board-members-executive-committee/)
Prior to Vertex, Joy Liu spent 14 years at Ropes & Gray LLP, including five as Partner, advising drug, biotech, and device companies on FDA regulatory matters such as approval strategies, advertising, promotion, Hatch-Waxman, and orphan exclusivity.[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/joy-liu)[[2]](https://www.conferencesforwomen.org/speakers/joy-liu/) She holds an A.B. in Government from Harvard University and a Doctor of Law (J.D.) from Columbia Law School.[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/joy-liu)[[2]](https://www.conferencesforwomen.org/speakers/joy-liu/)[[3]](https://rocketreach.co/joy-liu-email_392453638) Recognized as a leading life sciences lawyer by Chambers USA, Law360 Rising Star, and Washington D.C. '40 under 40,' Liu recently disclosed ownership of 23,703 VRTX shares and vested stock options as EVP and Chief Legal Officer.[[2]](https://www.conferencesforwomen.org/speakers/joy-liu/)[[4]](https://www.stocktitan.net/sec-filings/VRTX/form-3-vertex-pharmaceuticals-inc-ma-initial-statement-of-beneficial--64465f9ca03d.html)
View full insider profile →
